Free Trial
LON:CEL

Celadon Pharmaceuticals (CEL) Share Price, News & Analysis

Celadon Pharmaceuticals logo
GBX 13.40 0.00 (0.00%)
As of 08/6/2025

About Celadon Pharmaceuticals Stock (LON:CEL)

Key Stats

Today's Range
13.40
13.40
50-Day Range
9
13.79
52-Week Range
2.21
83
Volume
N/A
Average Volume
226,267 shs
Market Capitalization
£8.22 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CEL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Celadon Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CEL Stock News Headlines

Capital Gains Tax Strategies for Seniors
Capital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holding investments longer to using tax-advantaged accounts and strategic loss offsetting, there are ways to reduce your exposure. SmartAsset outlines three capital gains tax strategies for seniors and offers a free tool to connect you with vetted fiduciary financial advisors who can help tailor these tactics to your situation.tc pixel
See More Headlines

CEL Stock Analysis - Frequently Asked Questions

Celadon Pharmaceuticals' stock was trading at GBX 14 at the beginning of the year. Since then, CEL stock has decreased by 4.3% and is now trading at GBX 13.40.

Shares of CEL stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Celadon Pharmaceuticals investors own include AutoZone (AZO), Bahamas Petroleum (BPC), Intel (INTC), TJX Companies (TJX), Abacus Health Products (ABAHF), Avino Silver & Gold Mines (ASM) and Bank of America (BAC).

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
Communication
Current Symbol
LON:CEL
CIK
N/A
Fax
N/A
Employees
2,780
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX (7.98)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£4.97 million
Net Margins
-4,024.62%
Pretax Margin
N/A
Return on Equity
-187.26%
Return on Assets
-34.40%

Debt

Debt-to-Equity Ratio
196.67
Current Ratio
1.92
Quick Ratio
6.97

Sales & Book Value

Annual Sales
£123.38 thousand
Price / Sales
66.61
Cash Flow
GBX 4.39 per share
Price / Cash Flow
3.05
Book Value
GBX 3.80 per share
Price / Book
3.53

Miscellaneous

Outstanding Shares
61,329,971
Free Float
N/A
Market Cap
£8.22 million
Optionable
Not Optionable
Beta
-0.26
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

This page (LON:CEL) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners